Grupo Médico Camino S.C. - México

Grupo Médico Camino S.C. - México
Av. Cuauhtémoc 1251, Sta Cruz Atoyac, Benito Juárez, 03310 Ciudad de México, CDMX, Mexico
Select an option

Our team

Medical staff
Susana Gonzalez
Jorge Gavilan
Freddy Guillermo Castro Farfan
Claudia Elisa Alfaro Tapia
Mayra Aguilar Lopez
Maricela Escobar
Eunice Morales Peralta

Open studies

Breast Cancer
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer - EMBER-4 - Eli Lilly and CompanySee more
Diabetes
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes - TREASURE-CKD - Eli Lilly and CompanySee more
Epilepsies
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) - X-TOLE3 - Xenon Pharmaceuticals Inc.See more
Obesity
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes - TREASURE-CKD - Eli Lilly and CompanySee more
Renal disease
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes - TREASURE-CKD - Eli Lilly and CompanySee more
Seizure
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures - X-ACKT - Xenon Pharmaceuticals Inc.See more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy